Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/430139
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2022-12-22T17:16:02Z-
dc.date.available2022-12-22T17:16:02Z-
dc.identifier.urihttp://hdl.handle.net/10603/430139-
dc.description.abstractEukaryotic cellular pathways are maintained and coordinated through biomolecule turnover, which includes synthesis, trafficking, degradation of cellular components and their reutilization. The process of biomolecule degradation has been shown to modulate the cellular homeostasis. Lipid degradation in mammalian cells occurs in membrane-bound organelles called lysosomes and is carried out by acid hydrolases. Mutations in the lysosomal enzymes or their defective trafficking lead to the accumulation of degradative substrates resulting in lysosome dysfunction, observed in a group (~60 types) of genetic diseases known as lysosomal storage disorders/diseases (LSDs). In the past one decade, LSDs in India have surged and 374 cases have been reported so far, wherein 34% patients suffer from Gaucherand#8223;s disease. In line, Gaucherand#8223;s disease has been the most common LSD reported in the world. This disorder is caused by mutations in the gene GBA1 that encodes for lysosomal enzyme acid and#61538;-glucosidase or and#61538;-glucocerebrosidase (and#61538;-GC). Most commonly, mutations in and#61538;-GC lead to its misfolding and is subjected to ER-associated proteasomal degradation (ERAD) that impairs the trafficking of enzyme to lysosomes. This process results in accumulation of the substrate glucosylceramide causing lysosome dysfunction that lead to hepatomegaly and splenomegaly. It has been shown that few of the and#61538;-GC mutants lead to the neuropathic form of the disease, which affects the central nervous system. Currently, enzyme replacement (ERT) and substrate reduction (SRT) therapies are used to cure the non-neuropathic Gaucherand#8223;s disease. In this study, we aimed to modulate the cellular pathways that control the folding and trafficking of mutant and#61538;-GC to lysosome. Cellular phosphatases/kinases are known to alter these proteostasis pathways through a post-translation modification. Thus, we studied the role of phosphatases and kinases in regulating lysosome function following their effect on Gaucherand#8223;s disease. The current study entitled as Unraveling the role of c...
dc.format.extent
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleUnraveling the role of cellular phosphatases in lysosome function and storage diseases
dc.title.alternativeUnraveling the role of cellular phosphatases in lysosome function and storage diseases
dc.creator.researcherPatel, Saloni
dc.subject.keywordLife Sciences
dc.subject.keywordMicrobiology
dc.description.note
dc.contributor.guideSetty, Subba Rao G
dc.publisher.placeBangalore
dc.publisher.universityIndian Institute of Science Bangalore
dc.publisher.institutionMicrobiology and Cell Biology
dc.date.registered
dc.date.completed2019
dc.date.awarded2019
dc.format.dimensions
dc.format.accompanyingmaterialNone
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Microbiology and Cell Biology

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File115.06 kBAdobe PDFView/Open
02_prelim page.pdf850.66 kBAdobe PDFView/Open
03_table of content.pdf268.24 kBAdobe PDFView/Open
04_abstract.pdf280.57 kBAdobe PDFView/Open
05_chapter1.pdf3.29 MBAdobe PDFView/Open
06_chapter2.pdf377.24 kBAdobe PDFView/Open
07_chapter3.pdf1.5 MBAdobe PDFView/Open
08_chapter4.pdf3.13 MBAdobe PDFView/Open
09_chapter5.pdf1.78 MBAdobe PDFView/Open
10_annexure.pdf238.09 kBAdobe PDFView/Open
80_recommendation.pdf324.12 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: